The trademark application ERZOFRI was filed by Geneora Pharma (Shijiazhuang) Co., Ltd., a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on May 3, 2022, and it was registered by office on August 10, 2022 without any oppositions.
The application was filed in English (Spanish was selected as the second language).
Change of name and professional address of the trademark registration was recorded on March 28, 2022. A transfer of the trademark registration was recorded on January 11, 2023.
Goods And Services
The mark was filed in class 5 with following description of goods:
Medicines for human purposes
Chemical preparations for pharmaceutical purposes
Biochemical preparations for medical use
Pharmaceutical preparations
Medicines for veterinary purposes
Chemico-pharmaceutical preparations
Pharmaceutical products for the treatment of depression
Dietetic substances adapted for medical use
Dressings, medical
Pharmaceutical preparations for treatment of schizophrenia in adults
Pharmaceutical preparations for treatment of schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants.